Rebecca Chambers

Rebecca Chambers has extensive healthcare leadership experience, previously serving as Chief Financial Officer for Outset Medical, a publicly traded medical technology company focused on reducing dialysis costs and complexity. While at Outset Medical, Ms. Chambers led the company through a new debt arrangement, Series E fundraising, IPO, and multiple follow-on offerings. Prior to joining Outset, Ms. Chambers served in several financial roles at Illumina, including Vice President of Financial Planning and Analysis, Vice President of Investor Relations and Treasury, and Senior Director of Investor Relations. She has also served as head of Investor Relations and Corporate Communications at Myriad Genetics and held various roles in investor relations at Life Technologies. Earlier in her career, Ms. Chambers served as a Vice President at Bank of America and a Senior Research Associate at Millennium Pharmaceuticals (now part of Takeda Pharmaceuticals). Ms. Chambers serves on the board of Inari Medical, a medical device company focused on venous diseases. She holds a B.S. in Biology from John Carroll University and an M.B.A. from The S.C. Johnson Graduate School of Management at Cornell University.